IDM PHARMA (NASDAQ:IDMI)
2.62
-0 (-0%)
| IDM PHARMA (NASDAQ:IDMI) Delayed : |
| Previous Close |
$2.62 |
|
52 Week High |
$3.75 |
|
| Open |
$2.62 |
|
52 Week Low |
$1.34 |
| Day High |
$2.62 |
|
P/E |
N/A |
| Day Low |
$2.62 |
|
EPS |
$-0.47 |
| Volume |
58,821 |
|
|
|
| More IDMI Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on IDMI
-
May 18, 2009 12:53 PM
Unusual 11 Mid-Day Movers 5/18: KONA, IDMI, GRO, REDF Higher; SPIR, EDZ, COIN, FAZ Lower
-
May 18, 2009 10:25 AM
Notable Mergers and Acquisitions of the Day 5/18: KONA, IDMI, CF/AGU, VR/IPCR, AMSWA/LGTY
-
May 18, 2009 10:07 AM
Morning Movers 5/18: KONA, AHR, IDMI, LGTY, IBN, HEB Higher; SPIR, COIN, BIDZ, AYE Lower
-
May 18, 2009 06:57 AM
Takeda To Acquire IDM Pharma (IDMI) at 55% Premium
-
Mar 31, 2009 08:13 AM
IDM Pharma (IDMI) Reports Q4 Loss of $0.07
View All Reports
StreetInsider Reports on IDMI by Category
Comments on recent IDMI articles
Comments on IDMI
No comments are currently available.
on Feb 20, 2008
at 08:13 PM Rodman misses The problem with Rodman's take is that the news was not new data, it was confirmation of the old data by the Children's Oncology Group in a peer reviewed journal, Journal of Clinical Oncology. Furthermore, the 500% run up was due to massive insider buying by Palo Alto Investors, including associates. They were already the largest shareholder and they quadrupled their holdings from 2.1m shares to over 8. I don't know which is worse, that they knew about it but failed to mention, or that they did not know about it.
Article: Rodman & Renshaw downgrades Momentum Mover IDM Pharma (IDMI) to Market Underperform
on Feb 20, 2008
at 11:56 AM This Stock is Dead Meat back to $0.50
Article: Rodman & Renshaw downgrades Momentum Mover IDM Pharma (IDMI) to Market Underperform
on Feb 20, 2008
at 11:53 AM IDMI How many shares short are you guys? Idiots!!
Article: Rodman & Renshaw downgrades Momentum Mover IDM Pharma (IDMI) to Market Underperform